These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1078 related articles for article (PubMed ID: 15299039)

  • 21. HIFs, hypoxia, and vascular development.
    Covello KL; Simon MC
    Curr Top Dev Biol; 2004; 62():37-54. PubMed ID: 15522738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators.
    Déry MA; Michaud MD; Richard DE
    Int J Biochem Cell Biol; 2005 Mar; 37(3):535-40. PubMed ID: 15618010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections.
    Kempf VA; Lebiedziejewski M; Alitalo K; Wälzlein JH; Ehehalt U; Fiebig J; Huber S; Schütt B; Sander CA; Müller S; Grassl G; Yazdi AS; Brehm B; Autenrieth IB
    Circulation; 2005 Mar; 111(8):1054-62. PubMed ID: 15723970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption.
    Papandreou I; Cairns RA; Fontana L; Lim AL; Denko NC
    Cell Metab; 2006 Mar; 3(3):187-97. PubMed ID: 16517406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of HIF: asparaginyl hydroxylation.
    Peet D; Linke S
    Novartis Found Symp; 2006; 272():37-49; discussion 49-53, 131-40. PubMed ID: 16686428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIF at the crossroads between ischemia and carcinogenesis.
    Paul SA; Simons JW; Mabjeesh NJ
    J Cell Physiol; 2004 Jul; 200(1):20-30. PubMed ID: 15137054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications.
    Brahimi-Horn C; Mazure N; Pouysségur J
    Cell Signal; 2005 Jan; 17(1):1-9. PubMed ID: 15451019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hypoxia-inducible factor and tumor progression along the angiogenic pathway.
    Brahimi-Horn MC; Pouysségur J
    Int Rev Cytol; 2005; 242():157-213. PubMed ID: 15598469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anemia and cerebral outcomes: many questions, fewer answers.
    Hare GM; Tsui AK; McLaren AT; Ragoonanan TE; Yu J; Mazer CD
    Anesth Analg; 2008 Oct; 107(4):1356-70. PubMed ID: 18806052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate carcinoma cells selected by long-term exposure to reduced oxygen tension show remarkable biochemical plasticity via modulation of superoxide, HIF-1alpha levels, and energy metabolism.
    Bourdeau-Heller J; Oberley TD
    J Cell Physiol; 2007 Sep; 212(3):744-52. PubMed ID: 17458899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-Jun NH2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent P-glycoprotein expression in hypoxia.
    Comerford KM; Cummins EP; Taylor CT
    Cancer Res; 2004 Dec; 64(24):9057-61. PubMed ID: 15604272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart.
    Huang Y; Hickey RP; Yeh JL; Liu D; Dadak A; Young LH; Johnson RS; Giordano FJ
    FASEB J; 2004 Jul; 18(10):1138-40. PubMed ID: 15132980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology.
    Acker T; Plate KH
    J Mol Med (Berl); 2002 Sep; 80(9):562-75. PubMed ID: 12226738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues.
    Soilleux EJ; Turley H; Tian YM; Pugh CW; Gatter KC; Harris AL
    Histopathology; 2005 Dec; 47(6):602-10. PubMed ID: 16324198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIF-1 as a target for drug development.
    Giaccia A; Siim BG; Johnson RS
    Nat Rev Drug Discov; 2003 Oct; 2(10):803-11. PubMed ID: 14526383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous 2-oxoacids differentially regulate expression of oxygen sensors.
    Dalgard CL; Lu H; Mohyeldin A; Verma A
    Biochem J; 2004 Jun; 380(Pt 2):419-24. PubMed ID: 14984367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of hypoxia inducible factors (HIF) in hypoxia and normoxia during placental development.
    Patel J; Landers K; Mortimer RH; Richard K
    Placenta; 2010 Nov; 31(11):951-7. PubMed ID: 20869770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia.
    Taylor CT; Moncada S
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):643-7. PubMed ID: 19713530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of calcium in hypoxia-induced signal transduction and gene expression.
    Seta KA; Yuan Y; Spicer Z; Lu G; Bedard J; Ferguson TK; Pathrose P; Cole-Strauss A; Kaufhold A; Millhorn DE
    Cell Calcium; 2004; 36(3-4):331-40. PubMed ID: 15261489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIF-1: hypoxia-inducible factor or dysoxia-inducible factor?
    López-Lázaro M
    FASEB J; 2006 May; 20(7):828-32. PubMed ID: 16675839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.